ÂÜÀòÂÒÂ×

Pingjuan Li is an experienced Associate Director and Principal Scientist in the field of AAV engineering via directed evolution. With a background in gene therapy and CRISPR/Cas9-mediated gene editing, Pingjuan has worked at various prestigious institutions such as Harvard Medical School, The Massachusetts Eye and Ear Infirmary, and the FDA. Pingjuan's expertise includes designing NHP studies, managing research associates, and collaborating with external partners. Pingjuan holds a Doctor of Medicine (M.D.) degree from Zhengzhou University School of Medicine.